Hong Kong, China vs Kyrgyzstan: New or unknown treatment history cases: Pulmonary, bacteriologically
Hong Kong, China
2,090
in 2023
Kyrgyzstan
2,191
in 2023
Hong Kong, China rank
92nd
Kyrgyzstan rank
89th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Hong Kong, China
- Kyrgyzstan
How they compare
Kyrgyzstan currently reports 2,191 against 2,090 in Hong Kong, China, a difference of 101.
The two have swapped places 5 times across 11 shared years of data; in 2013 it was Hong Kong, China ahead.
Hong Kong, China ranks 92nd and Kyrgyzstan ranks 89th of 197 countries.
Hong Kong, China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,336 | 2,321 | 15.29 | Hong Kong, China |
| 2020s | 2,150 | 2,078 | 71.75 | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Hong Kong, China or Kyrgyzstan?
- Kyrgyzstan, at 2,191 against 2,090 in Hong Kong, China as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Hong Kong, China and Kyrgyzstan?
- 101, with Kyrgyzstan ahead.
- How many years of comparable data are there for Hong Kong, China and Kyrgyzstan?
- 11 years are reported by both, from 2013 to 2023.
- How do Hong Kong, China and Kyrgyzstan rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Hong Kong, China ranks 92nd and Kyrgyzstan ranks 89th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.